Literature DB >> 28988527

How Fucose of Blood Group Glycotopes Programs Human Gut Microbiota.

S V Kononova1.   

Abstract

Formation of appropriate gut microbiota is essential for human health. The first two years of life is the critical period for this process. Selection of mutualistic microorganisms of the intestinal microbiota is controlled by the FUT2 and FUT3 genes that encode fucosyltransferases, enzymes responsible for the synthesis of fucosylated glycan structures of mucins and milk oligosaccharides. In this review, the mechanisms of the selection and maintenance of intestinal microorganisms that involve fucosylated oligosaccharides of breast milk and mucins of the newborn's intestine are described. Possible reasons for the use of fucose, and not sialic acid, as the major biological signal for the selection are also discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28988527     DOI: 10.1134/S0006297917090012

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  4 in total

1.  Glyco-engineered cell line and computational docking studies reveals enterotoxigenic Escherichia coli CFA/I fimbriae bind to Lewis a glycans.

Authors:  Lynda Mottram; Jining Liu; Sonali Chavan; Joshua Tobias; Ann-Mari Svennerholm; Jan Holgersson
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

Review 2.  Acceptive Immunity: The Role of Fucosylated Glycans in Human Host-Microbiome Interactions.

Authors:  Svetlana Kononova; Ekaterina Litvinova; Timur Vakhitov; Maria Skalinskaya; Stanislav Sitkin
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 3.  Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases.

Authors:  Mingyang Hu; Xiyun Zhang; Jinze Li; Luotong Chen; Xiaolin He; Tingting Sui
Journal:  Front Microbiol       Date:  2022-07-18       Impact factor: 6.064

Review 4.  Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi.

Authors:  Richard M Merkhofer; Bruce S Klein
Journal:  Front Cell Infect Microbiol       Date:  2020-02-28       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.